Abstract
Lipstatin, a new and very potent inhibitor of pancreatic lipase (the key enzyme of in-testinal fat digestion) was isolated from Streptomyces toxytricini. Lipstatin contains a structure that probably accounts for the irreversible lipase inhibition. The IC50 of lipstatin for pancreatic lipase is 0.14. In mice triolein absorption was dose-dependently inhibited by lipstatin, whereas oleic acid was absorbed normally. Other pancreatic enzymes, such as phospholipase A2 and trypsin, were not inhibited even at an inhibitor concentration of 200 μm. © 1987, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.
Cite
CITATION STYLE
Weibel, E. K., Hadvary, P., Hochuli, E., Kupfer, E., & Lengsfeld, H. (1987). Lipstatin, an inhibitor of pancreatic lipase, produced by streptomyces toxytricini i. producing organism, fermentation, isolation and biological activity. The Journal of Antibiotics, 40(8), 1081–1085. https://doi.org/10.7164/antibiotics.40.1081
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.